Diabetes and the American Healthcare System

I am pleased to share our just completed healthcare use case scenario in story telling format.

We selected diabetes mellitus (type 2) as a scenario to demonstrate the value of the Kyield platform to healthcare. Given the very high cost of healthcare in the U.S. currently with an unsustainable economic trajectory, it’s essential that costs be driven lower while improving care. Diabetes type 2 has direct costs exceeding $200 billion annually in the U.S. alone, the majority of which is entirely preventable.

The most obvious method to overcome this significant challenge is with far more intelligent HIT systems. It is not surprising that the legislation appears to be perfectly matched for the Kyield PaaS– nor is it entirely accidental as our mission aligns well with the needs in healthcare; an R&D process that began more than a decade ago.

This was a challenging scenario to develop and write due to the complexity of the disease, large body of regulations, incomplete standards, and varying interests between the partners in the ecosystem.  A bit of extra personal motivation for me was that my father died a few years ago from complications from diabetes, which was diagnosed shortly after my brother died of ALS. Ever since the shocking phone call from my brother informing me of his “death sentence” in the summer of 1997, I have followed ALS research; among the most complex and brutal diseases.

Diabetes type 2 is also complex, but unlike ALS and many other diseases, diabetes type 2 is largely preventable with a relatively modest change in behavior and lifestyle– modest indeed particularly compared to the later stage affects of the disease in absence of prevention, which we highlight in this use case. It’s difficult to understand after watching my father’s disease progress for a decade why anyone would not want to prevent diabetes– it literally destroys the human body.

I hope you find the case interesting and valuable. I am confident that if followed in a similar path as outlined in this scenario, the platform will contribute to significantly more effective prevention and healthcare delivery at a lower cost.

Diabetes Use Case Scenario (PDF)

Mark Montgomery